CDC Proclaims Racism Public Health Crisis, Calls for Health Equity

A new mandate out of the Centers for Disease Control & Prevention has asserted systemic racism as a public health crisis, a step the agency says will build the foundation to improve health equity.

The statement from CDC’s director Rochelle P. Walensky, MD, MPH, acknowledged the racial health disparities seen in traditionally marginalized communities, including the Black, Latinx, and American Indian/Alaska Native (AI/AN) populations.

“Yet, the disparities seen over the past year were not a result of COVID-19,” Walensky said in the written statement. “Instead, the pandemic illuminated inequities that have existed for generations and revealed for all of America a known, but often unaddressed, epidemic impacting public health: racism.”

Guests: 

Yele Aluko, MD, MBA
Chief Medical Officer
EY Americas

Dr. Yele Aluko is the chief medical officer in EY Americas Business Consulting Health Sector. He is a proven physician executive and leader, with 25 years of clinical and administrative health system experience prior to joining Ernst & Young LLP in 2016. He advises health system clients on strategy, business and clinical operations providing C-Suite executives insight on health industry megatrends and enterprise growth opportunities. He is a member of the EY COVID-19 Pandemic Response Team where he advises EY leadership on return-to-workplace strategies that prioritize the health and safety of its employees. As a member of the EY COVID-19 Enterprise Resiliency Team, he provides client insight on return-to-work strategies and solutions designed to preserve workforce well-being and safety during and in the aftermath of COVID-19. He is a leader in the development of the EY Point of View on Health Equity and has designed solutions for clients seeking competencies relevant to elimination of health disparities and achieving health equity.

As chief medical officer, he is a leader within EY physician enterprise operations and clinical integration practice where he assists health care system clients in physician engagement and alignment, provider accountability for value delivery, and defining and maximizing physician enterprise value for health care systems. He has supported organizations as they transition to integrated service line models of care delivery and recognizes the medical group’s impact on driving clinical quality initiatives.

He is a former structural heart cardiologist and senior vice president of heart and vascular services at a 15-hospital integrated regional health care system in the southeast USA. His responsibilities included governance of an enterprise-wide clinical strategy overseeing cardiovascular service line vision, growth, clinical integration, physician alignment and standardization of clinical, operational and business processes.

He obtained his doctor of medicine from the University College Hospital, Nigeria. He trained in internal medicine and cardiology at the College of Physicians and Surgeons of Columbia University and in invasive and interventional cardiology at Cornell University and University of Massachusetts Medical Center. He is board certified by the Canadian Board of Internal Medicine and is triple-board certified in internal medicine, cardiology and interventional cardiology by the American Board of Internal Medicine.

Gil Bashe
Managing Partner, Global Health
Finn Partners

Gil Bashe’s healthcare career spans the patient, physician, provider, payer and policy sectors. At the center of Gil’s life and work is the belief that communication is part of the care. As managing partner of Finn Partners Global Health, he champions the talent and ideas of the nation’s “Healthcare Agency of the Year” (Holmes Report).

Prior to joining Finn Partners, Gil was Executive Vice President and Health Practice Head at Makovsky and Hill & Knowlton. During his tenure, he took on some of the health sector’s most vexing reimbursement and access challenges. As a result, he was named by PRNews as one of the nation’s “Top Crisis Communicators” and inducted into its Hall of Fame.

Gil is passionate about public health in everything he does. He serves on the NHLBI GENTAC Working Group examining how genetics impacts cardiovascular disease and the health/tech advisory committee for mHealth Israel. He is immediate past chair of the American Heart Association Northeast Founder’s Affiliate.

Gil is also an advisory board member of the Prix Galien Foundation, referred to as the Nobel Prize for health innovation. Gil is a past national board member of the Leukemia and Lymphoma Society and American Academy of Pain Medicine Foundation. Always ready to share knowledge, Gil is a columnist for PM360 magazine, speaker on patient advocacy and health communications and co-editor of the book Branding Health Services: Defining Yourself in the Marketplace.

CDC Proclaims Racism Public Health Crisis, Calls for Health Equity
A new&nbsp;<a href="https://www.cdc.gov/media/releases/2021/s0408-racism-health.html">mandate</a>&nbsp;out of the Centers for Disease Control &amp; Prevention has asserted systemic racism as a public health crisis, a step the agency says will build the foundation to improve health equity.
The statement from CDC&rsquo;s director Rochelle P. Walensky, MD, MPH, acknowledged the racial health disparities seen in traditionally marginalized communities, including the Black, Latinx, and American Indian/Alaska Native (AI/AN) populations.
&ldquo;Yet, the disparities seen over the past year were not a result of COVID-19,&rdquo; Walensky said in the written statement. &ldquo;Instead, the pandemic illuminated inequities that have existed for generations and revealed for all of America a known, but often unaddressed, epidemic impacting public health: racism.&rdquo;
Guests:&nbsp;
Yele Aluko, MD, MBA Chief Medical Officer EY Americas
Dr. Yele Aluko is the chief medical officer in EY Americas Business Consulting Health Sector. He is a proven physician executive and leader, with 25 years of clinical and administrative health system experience prior to joining Ernst &amp; Young LLP in 2016. He advises health system clients on strategy, business and clinical operations providing C-Suite executives insight on health industry megatrends and enterprise growth opportunities. He is a member of the EY COVID-19 Pandemic Response Team where he advises EY leadership on return-to-workplace strategies that prioritize the health and safety of its employees. As a member of the EY COVID-19 Enterprise Resiliency Team, he provides client insight on return-to-work strategies and solutions designed to preserve workforce well-being and safety during and in the aftermath of COVID-19. He is a leader in the development of the EY Point of View on Health Equity and has designed solutions for clients seeking competencies relevant to elimination of health disparities and achieving health equity.
As chief medical officer, he is a leader within EY physician enterprise operations and clinical integration practice where he assists health care system clients in physician engagement and alignment, provider accountability for value delivery, and defining and maximizing physician enterprise value for health care systems. He has supported organizations as they transition to integrated service line models of care delivery and recognizes the medical group&rsquo;s impact on driving clinical quality initiatives.
He is a former structural heart cardiologist and senior vice president of heart and vascular services at a 15-hospital integrated regional health care system in the southeast USA. His responsibilities included governance of an enterprise-wide clinical strategy overseeing cardiovascular service line vision, growth, clinical integration, physician alignment and standardization of clinical, operational and business processes.
He obtained his doctor of medicine from the University College Hospital, Nigeria. He trained in internal medicine and cardiology at the College of Physicians and Surgeons of Columbia University and in invasive and interventional cardiology at Cornell University and University of Massachusetts Medical Center. He is board certified by the Canadian Board of Internal Medicine and is triple-board certified in internal medicine, cardiology and interventional cardiology by the American Board of Internal Medicine.
Gil Bashe Managing Partner, Global Health Finn Partners
Gil Bashe&rsquo;s healthcare career spans the patient, physician, provider, payer and policy sectors. At the center of Gil&rsquo;s life and work is the belief that communication is part of the care. As managing partner of Finn Partners Global Health, he champions the talent and ideas of the nation&rsquo;s &ldquo;Healthcare Agency of the Year&rdquo; (Holmes Report). Prior to joining Finn Partners, Gil was Executive Vice President and Health Practice Head at Makovsky and Hill &amp; Knowlton. During his tenure, he took on some of the health sector&rsquo;s most vexing reimbursement and access challenges. As a result, he was named by PRNews as one of the nation&rsquo;s &ldquo;Top Crisis Communicators&rdquo; and inducted into its Hall of Fame. Gil is passionate about public health in everything he does. He serves on the NHLBI GENTAC Working Group examining how genetics impacts cardiovascular disease and the health/tech advisory committee for mHealth Israel. He is immediate past chair of the American Heart Association Northeast Founder&rsquo;s Affiliate. Gil is also an advisory board member of the Prix Galien Foundation, referred to as the Nobel Prize for health innovation. Gil is a past national board member of the Leukemia and Lymphoma Society and American Academy of Pain Medicine Foundation. Always ready to share knowledge, Gil is a columnist for PM360 magazine, speaker on patient advocacy and health communications and co-editor of the book Branding Health Services: Defining Yourself in the Marketplace.

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.
The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.
The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.
The definition of &ldquo;Innovation&rdquo; is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare &amp; the PPN is the Pharmacist's biggest fan.&nbsp;

Pharmacy Podcast Network

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Business of Pharmacy and TOP 25 Podcasts in U.S. Business News. The most influential voices in the pharmacy industry are published on the Pharmacy Podcast Network (PPN). The PPN is the leading audio authority of the pharmaceutical & pharmacy industry with more than 30 hosts, 1,200+ episodes, supporting more than 25+ pharmacy industry associations, with more than 80,000 listeners world wide. 

The PPN is an Audio Branding & Public Relations Communications company dedicated to the Pharmaceutical industry focusing on Community, Long-term care, Health System, Specialty, pharmacy business supportive technologies, and industry trends. 

Pharmacy Podcast™ is a registered trademark

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Business of Pharmacy and TOP 25 Podcasts in U.S. Business News. The most influential voices in the pharmacy industry are published on the Pharmacy Podcast Network (PPN). The PPN is the leading audio authority of the pharmaceutical &amp; pharmacy industry with more than 30 hosts, 1,200+ episodes, supporting more than 25+ pharmacy industry associations, with more than 80,000 listeners world wide.&nbsp;
The PPN is an Audio Branding &amp; Public Relations Communications company dedicated to the Pharmaceutical industry focusing on Community, Long-term care, Health System, Specialty, pharmacy business supportive technologies, and industry trends.&nbsp;
Pharmacy Podcast&trade; is a registered trademark

Advertisement